Skip to main content

Table 17 Anti-inflammatory screening results

From: Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review

Comp. Paw oedema thickness (mm)
30 m (X ± SE) Oedema
Inhibition (%)
60 m (X ± SE) Oedema
Inhibition (%)
Control 1.3 ± 0.05 1.5 ± 0.03
17a 1.1 ± 0.03 15.3 1.1 ± 0.00 26.6
17b 1.2 ± 0.03 7.6 1.1 ± 0.06 26.6
Nimesulide 1.1 ± 0.05 15.3 1.1 ± 0.00 26.6